Groundbreaking bone cancer treatment achieves 99% success rate
Bioactive glasses, a specialized material that can bond with tissue and improve the strength of bones and teeth, are now showing promise as a potential treatment for bone cancer. By combining bioactive glass with gallium, researchers have developed a treatment with impressive potential to eliminate cancerous cells while regenerating diseased bones. Aston University scientists, led by Professor Richard Martin from the College of Engineering and Physical Sciences, spearheaded the research. Their studies have yielded encouraging results: bioactive glass doped with gallium eliminated 99% of osteosarcoma (bone cancer) cells in laboratory tests. Importantly, this success was achieved without harming healthy human bone cells. Osteosarcoma is one of the most common primary bone cancers, but despite decades of research and advances in chemotherapy and surgery, survival rates have not improved significantly since the 1970s. Worse, survival rates drop dramatically for patients whose cancer recurs. Patients with primary bone cancer are also highly prone to bone fractures due to the damage caused by both the disease and its treatment. Professor Richard Martin. (CREDIT: Aston University) The key to …